A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

NCT05165849 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped sponsor decided to withdraw the study

Conditions

Solid Tumor

Interventions

DRUG: GFS101A
DRUG: Toripalimab

Sponsor

Zhejiang Genfleet Therapeutics Co., Ltd.